Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine

Details

• Alternative Title:
  Emerg Infect Dis
• Personal Author:
  Hunsawong, Taweewun ; Fernandez, Stefan ; Buathong, Rome ; Khadthasrima, Naretrit ; Rungrojchareonkit, Kamonthip ; Lohachanakul, Jindarat ; Suthangkornkul, Rungarun ; Tayong, Kedsara ; Huang, Angkana T. ; Klungthong, Chonticha ; Chinnawirotpisan, Piyawan ; Poolpanichupatam, Yongyuth ; Jones, Anthony R. ; Lombardini, Eric D. ; Wacharapluesadee, Supaporn ; Putcharoen, Opass
• Description:
  In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provide support for vaccine boosters, especially variants of concern circulate.
• Subjects:
  Antibodies, Neutralizing Antibodies, Viral Coronavirus Infections Covid-19 Covid-19 Vaccines Humans
• Source:
  Emerg Infect Dis. 2021; 27(12):3178-3180
• Pubmed ID:
  34559045
• Pubmed Central ID:
  PMC8632161
• Document Type:
  Journal Article
• Funding:
  U01 AI151797/AI/NIAID NIH HHSUnited States/
• Genre:
  Letter
• Place as Subject:
  Thailand
• Volume:
  27
• Issue:
  12
• Collection(s):
  Emerging Infectious Diseases
• Main Document Checksum:
  urn:sha256:165cd56146287ff22fdf15718a21144d6ae2fab928c6a5fc02a95397421d3f12
• Download URL:
  https://stacks.cdc.gov/view/cdc/112633/cdc_112633_DS1.pdf
• File Type:
  [PDF - 1.03 MB ]